renal cancer

Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
Clinical Trials Arena
Thu, 10/3/24 - 10:37 am
Arcus Biosciences
AstraZeneca
renal cancer
casdatifan
renal cell carcinoma
ESMO 2022 – Keytruda secures a renal cancer monopoly
EP Vantage
Thu, 09/8/22 - 12:03 am
Merck
Keytruda
renal cancer
Bristol Myers Squibb
Roche
ESMO
3 Big Pharma Stocks With Credible Threats to Their Blockbusters
24/7 Wall St
Fri, 05/6/16 - 10:52 am
Pfizer
renal cancer
Sutent
cabozantinib
Exelixis
AstraZeneca
Faslodex
breast cancer
Atossa Genetics
Merck
Zetia
Mylan Labs
Pfizer: Renal Cancer Treatment Sutent Sales Forecast
Seeking Alpha
Mon, 06/17/13 - 11:00 am
renal cancer
Pfizer
Sutent
Cellceutix Reports In Vivo Tumor Shrinkage in Renal Cancer
Yahoo
Thu, 01/24/13 - 11:12 am
Cellceutix
renal cancer
Kevetrin
Ampio Pharmaceuticals Expands Pipeline with Promising New Cancer Drug NCE001
Motley Fool
Sat, 07/21/12 - 11:42 am
Ampio Pharmaceuticals
NCE001
breast cancer
renal cancer
glioblastoma multiforme
AVEO: More Open Questions Than Answers
Seeking Alpha
Sun, 01/8/12 - 12:47 pm
Aveo Pharmaceutical
tivozanib
kidney cancer
renal cancer
FDA approves GlaxoSmithKline renal cancer drug
Marketwatch
Tue, 10/20/09 - 07:41 am
GSK
renal cancer
FDA
Votrient